US Patent Issued to H. Lee Moffitt Cancer Center and Research Institute on Oct. 28 for "Radiomics-based treatment decision support for lung cancer" (Florida Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,453,786, issued on Oct. 28, was assigned to H. Lee Moffitt Cancer Center and Research Institute Inc. (Tampa, Fla.).

"Radiomics-based treatment decision support for lung cancer" was invented by Robert J. Gillies (Tampa, Fla.), Matthew B. Schabath (Tampa, Fla.) and Wei Mu (Tampa, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Two major treatment strategies employed in fighting non-small cell lung cancer (NSCLC) are tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs). The choice of strategy is based on heterogeneous biomarkers expressed by the lung tumor tissue. A major challenge for molecular testing of these biomarkers is the i...